Anne-Kirsti Aksnes

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

Peter Hoskin, Oliver Sartor, Joe M. O’Sullivan et al. · The Lancet Oncology · 2014 · 403 citations

Urology, Medicine, Pharmacology +7

Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer

Jorge A. Carrasquillo, Joseph A. O’Donoghue, Neeta Pandit‐Taskar et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 179 citations · Full text

Urology, Oncology, Medicine +6

Exercise‐induced overexpression of key regulatory proteins involved in glucose uptake and metabolism in tetraplegic persons: molecular mechanism for improved glucose homeostasis

Nils Hjeltnes, Dana Galuska, Marie Björnholm et al. · The FASEB Journal · 1998 · 120 citations · Full text

A bone marrow toxicity model for²²³Ra alpha-emitter radiopharmaceutical therapy

Robert F. Hobbs, Hong Song, C Watchman et al. · Physics in Medicine and Biology · 2012 · 118 citations

Engineering, Radiation Exposure, Treatment Verification +22

18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)

Gary Cook, Chris Parker, Sue Chua et al. · EJNMMI Research · 2011 · 112 citations · Full text